Transdermal Drug Delivery Systems Market Size and Demand Analysis

Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market Overview

Transdermal drug delivery systems are a noninvasive method of systemic drug delivery that helps to implement a drug formulation to healthy, undamaged skin. Without building up in the dermal layer. The medication first goes via the stratum corneum and then deeper layers of epidermis and dermis. The transdermal drug delivery systems market is expected to generate significant revenue in the upcoming years.

The prevalence of chronic diseases like hypertension. Diabetes, and angina is rising, new drug delivery system technologies are becoming more widely used. Concerns about painless drug delivery and the advantages of transdermal drug delivery systems are growing. The count of patients with neurovascular disorders is rising.

Transdermal Drug Delivery Systems Market Growth

The enhancement of systemic bioavailability that results from avoiding first-pass metabolism is one of the advantages of employing transdermal drug delivery technologies. It is possible to exclude oral administration-related variables such as pH, the existence of food or enzymes, and transit periods.

Transdermal drug delivery systems also enable prompt treatment discontinuation in the event of any negative side effects. Structures made with textile materials are frequently permeable, pleasant, aesthetically pleasing, and breathable. They are also typically simple to use and may frequently be treated to increase their absorptive capacity.

Demand

Drugs are progressively absorbed into the systemic circulation when they are administered via the skin in a method known as transdermal medication delivery. The transdermal drug delivery systems market has been divided into passive and active delivery systems based on the kind of distribution method. Throughout the study period, the passive delivery method is anticipated to have a bigger share due to the rising prevalence of chronic diseases like hypertension and the increasing use of these devices.

Aside from that, rising disposable income and ever-improving healthcare infrastructure in developing nations are two other notable trends that are anticipated to provide participants in the market plenty of room to expand. Additionally, to meet the demands of an expanding patient pool, rising nations must concentrate on cost-effectiveness and scalability.

Due to significant government spending on healthcare and favorable reimbursement rules, North America has the biggest use of transdermal patches, which is followed by APAC and Europe, respectively. The APAC transdermal drug delivery systems market is predicted to have the fastest pace in the coming years. Due to better healthcare infrastructure and rising healthcare spending in emerging nations like China and India to meet unmet medical requirements, the area has experienced development.

Benefits of Transdermal Drug Delivery System

  • Avoiding medication first-pass metabolism
  • Drugs are continuously infused into the body by transdermal therapy over an extended period.
  • The streamlined prescription schedule results in increased patient compliance, a decrease in adverse effects, and less variation between and within patients.
  • No disruption of the digestive and gastrointestinal fluids
  • Keeps blood levels normal, constant, and under control for a longer length of time.
  • Properties that are comparable to intravenous infusion.

Market Drivers

The transdermal drug delivery systems market is expanding rapidly; it is attributed to the rising geriatric population and growing prevalence of chronic diseases such as angina, diabetes, hypertension and increased adoption of new drug delivery of new delivery system technologies. The rising concern toward painless drug delivery and numerous benefits facilitated by the transdermal drug delivery systems and the increasing number of patients suffering from neurological disorders proliferates the market.

There are two types of drug delivery systems, active and passive. Active delivery systems are expected to witness the fastest growth in the transdermal drug delivery systems market. While, passive drug delivery system is predicted to acquire a larger market share, ascribed to the rising prevalence of chronic diseases and the high adoption rate of drug delivery systems devices. The transdermal drug delivery systems are widely used in analgesics, hypertension, hormone replacement therapy, smoking cessation, motion sickness and others.

Key Compnay

The transdermal drug delivery systems market is propelling, attributed to the growing prevalence of chronic diseases. According to IDF, the number of diabetes patients is expected to reach 2.1 billion by 2050. In America, one in every three adults suffers from high blood pressure. According to the Centers of Disease Control and Prevention. The transdermal drug delivery systems devices are extensively used to treat such diseases and disorders.

The growing prevalence of hypertension worldwide leads to transdermal drug delivery systems market expansion. Around 1.28 billion adults aging between 30 to 79 are suffering from hypertension, signifying two-thirds of the population of low and middle-income countries affected by it. On average, 46% of people are unaware that they have hypertension. People having obese and follow an unhealthy diet that includes a high intake of salt, tobacco and alcohol are at increased risk for developing hypertension.

Industry Development

The increase in disposable income and consistent improvements in the healthcare infrastructure in developing countries expand the transdermal drug delivery systems market. It creates numerous opportunities for the market players to scale themselves. The availability of low-cost labor and economical materials leads to increased production of such devices, to cater to the requirements of the large customer base. The key players such as Novartis AG, Bayer AG, Boeringer Ingelheim GmbH, and Johnson & Johnson are dominating the market.

Under the application segment, analgesics dominate the transdermal drug delivery systems market. Attributed to their wide usage in hormone replacement therapy, cardiovascular disorders, hypertension and motion sickness. Due to the prevalence of cardiac disorders, the demand for analgesics has grown over the years. Ascribed to an increased number of patients suffering from heart diseases. The oral drug disadvantages and increased usage of the analgesics application in emergency drug delivery penetrates the market.

Therefore, the rise in the elderly population and the growing prevalence of chronic diseases drive the market.

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact: 

P&S Intelligence 
Phone: +1-347-960-6455 
Email: [email protected]
Web: https://www.psmarketresearch.com

 

 

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short

Leave a Reply

Your email address will not be published.